Sales Growth YoY (Last 12 Months): Janux Therapeutics (JANX)

Public company logo of Janux Corp (JANX)

Janux Therapeutics (JANX) price action is independent of macroeconomics, driven solely by the success of clinical trials. Comparable year-over-year sales growth over 12 months confirms business resilience, with the value 132.80 representing the current metric. Risks are linked to international patent protection and raw material logistics, however, sufficient liquidity reserves and the potential of T-cell platforms ensure stable access to investment.

Janux Therapeutics, Inc. (JANX) Revenue Growth YoY (Last 12 Months): for the period 02/11/2024 - 11/18/2026

Janux Therapeutics, Inc. (JANX) - metric breakdowns and financial figures

- market price and analyst price targets:
- company stock exchange capitalization indicators:
Summary company analytics:Janux Therapeutics
Product sample of januxrx.com

Stable revenue dynamics serve as the foundation for long-term investment attractiveness, while this 12-month YoY sales chart captures the daily growth rate of inflows relative to the previous year to eliminate quarterly gaps. For Janux Therapeutics (JANX), this indicator reflects the commercial efficiency of T-cell activator development, confirming that investments in leading immunologists and clinical trials are transforming into real market demand.

Competitors of Janux Therapeutics (JANX)

Sales Growth YoY (TTM) NantKwest IBRX|IMCR - Sales Growth YoY (Last Twelve Months)|RCUS (arcusbio.com) - Sales Growth YoY (Last 12 Months)|Zymeworks Biopharmaceuticals (ZYME) - Sales Growth YoY (Last Twelve Months)|Trailing Twelve Months Revenue Growth Tango Pharma (TNGX)|Revenue Growth YoY (Last 12 Months) IOVA|IMTX - Revenue Growth Rate YoY (Last Twelve Months)|Revenue Growth YoY (Last 12 Months) XNCR (Xencor Corp)|Revenue Change YoY (Last 12 Months) CMPX|Sales Growth YoY (TTM) REPL (Replimune)|Revenue Dynamics YoY (Last Twelve Months) LYEL|innate-pharma.com - Sales Growth YoY (TTM)|Trailing Twelve Months Revenue Growth Pyxis Oncology|Compugen Limited (CGEN) - Sales Growth YoY (Last Twelve Months)|IO Biotech, Inc. - Revenue Dynamics YoY (Last Twelve Months)|STRO (sutrobio.com) - Sales Growth YoY (TTM)|Sales Growth YoY (TTM) MiNK Therapeutics Inc.|Sales Growth YoY (Last Twelve Months) werewolftx.com (HOWL)|IMMX: Trailing Twelve Months Sales Growth|alxoncology.com - Revenue Growth YoY (Last 12 Months)|CUE - Revenue Growth YoY (Last 12 Months)|PDSB - Sales Growth YoY (Last Twelve Months)|Annual Revenue Growth (Last Twelve Months) Sonnet BioTherapeutics Holdings SONN|MAIA: Sales Growth YoY (TTM)|LIMN - Annual Revenue Growth (Last Twelve Months)|Revenue Growth YoY (Last 12 Months) LVTX|Sales Growth YoY (Last 12 Months) NXTC (NextCure)|Sales Growth YoY (Last Twelve Months) leaptx.com (LPTX)|INTS - Trailing Twelve Months Revenue Growth|Sales Growth YoY (TTM) SNSE (Sensei Biotherapeutics, Inc.)|Annual Revenue Growth (Last Twelve Months) Theriva Biologics, Inc. (TOVX)|GRTS: Revenue Growth YoY (Last 12 Months)|Annual Revenue Growth (Last Twelve Months) kinetabio.com KA|NEXI (neximmune.com) - Revenue Growth YoY (Last 12 Months)|Trailing Twelve Months Revenue Growth Turnstone Biologics Corporation (TSBX)|Revenue Growth YoY (Last 12 Months) VCNX|HARP: Revenue Dynamics YoY (Last Twelve Months)